Delivery Order SPE2DB22D1106-SPE2DB24FDVL7

Award Date 1/17/24
Potential Completion Date 1/18/24
Potential Value $1.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide $1,543.29 worth of the pharmaceutical product FLUTICASONE PROP HFA 110 MCG 12GM. The delivery order has a completion date of January 10, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and distribution services to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM medication. The order, valued at $4,462.34, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. The company also holds an indefinite delivery contract (IDC) with DLA,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM pharmaceuticals. The $6,296.40 award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of medications...
The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $8,762.72 firm fixed-price delivery order contract for the supply of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. This order was placed under an existing $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $6,371.70 worth of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. This delivery order contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is not designated as a...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563356119 - FLUTICASONE PROP HFA 44 MCG 10.6GM. The $3,806.45 contract has a completion date of January 19, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously received numerous federal contract awards from the Defense Logistics Agency to supply pharmaceuticals, medical supplies, and related...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,203,078 units of Fluticasone Prop HFA 220 MCG 12GM. The $14,671.63 contract has a completion date of January 2, 2024. As a prime contractor, Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and distribution services to support DLA programs. This...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDVL7
    Delivery Order

The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $1,595.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide FLUTICASONE PROP HFA 44 MCG 10.6GM pharmaceutical products. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to supply pharmaceuticals and medical supplies to support military treatment programs and facilities. The award has a completion date of January 18, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, operates primarily through its Corporate Office division to deliver a range of pharmaceutical and medical products to various U.S. government agencies, particularly the Department of Defense.

Generated 4/17/24, 9:28 AM